The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ClearPoint Neuro Inc shares valued at $322,400 were sold by BURNETT JOSEPH on Jan 09 ’26. At $16.12 per share, BURNETT JOSEPH sold 20,000 shares. The insider’s holdings dropped to 11,565 shares worth approximately $0.17 million following the completion of this transaction.
Also, JOSEPH M BURNETT purchased 20,000 shares, netting a total of over 306,200 in proceeds.
Before that, PTC Therapeutics, Inc. had added 894,578 shares to its account. In a trade valued at $14,787,374, the Affiliate of director bought ClearPoint Neuro Inc shares for $16.53 each.
Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in late October.
Analyzing CLPT Stock Performance
On last trading session, ClearPoint Neuro Inc [NASDAQ: CLPT] plunged -4.93% to $14.65. The stock’s lowest price that day was $14.38, but it reached a high of $15.22 in the same session. During the last five days, there has been a drop of approximately -4.31%. Over the course of the year, ClearPoint Neuro Inc shares have dropped approximately -0.31%.
Support And Resistance Levels for ClearPoint Neuro Inc (CLPT)
RSI (Relative Strength Index) is 49.71 on the 14-day chart, showing neutral technical sentiment.
Is ClearPoint Neuro Inc subject to short interest?
Stocks of ClearPoint Neuro Inc saw a sharp rise in short interest on 2025-12-31 jumping by 0.49 million shares to 3.04 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 2.56 million shares. A jump of 16.04% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.45 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.45.
Which companies own the most shares of ClearPoint Neuro Inc (CLPT)?
In terms of ClearPoint Neuro Inc share price expectations, FactSet research, analysts set an average price target of 15 in the next 12 months, down nearly -2.66% from the previous closing price of $15.41. Analysts anticipate ClearPoint Neuro Inc stock to reach 30 by 2026, with the lowest price target being 9. On March 18, 2021, Lake Street assigned a price target of “a Buy” to the stock and initiated coverage with a $32.
